DBV Technologies S.A. (DBVT): Nasdaq/NYSE listing notice — DBV Technologies receives Nasdaq deficiency notice for ADS bid price below $1.00

DBV Technologies S.A.

Nasdaq letter on Dec 20, 2023: DBVT ADS bid price below $1.00 for 30 consecutive business days.
Company has 180 days (until June 17, 2024) to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured, may qualify for additional 180-day period if meeting other listing standards and intending reverse split.
Company will monitor bid price and evaluate options to cure deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DBV Technologies S.A. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

December 20, 2023, DBV Technologies S.A. (the “Company”), received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s American Depositary Shares (“ADSs”) had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company’s ADSs on the Nasdaq Stock Market. In accordance with Nasdaq Listin

View on SEC.gov

Browse all listing & compliance notices →

DBV Technologies S.A. filing history →

Source: SEC EDGAR

accession 0001193125-23-301725

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.